Alteration of Enzyme Expressions in Mevalonate Pathway : – Possible Role for Cardiovascular Remodeling in Spontaneously Hypertensive Rats –
スポンサーリンク
概要
- 論文の詳細を見る
Background: The mevalonate pathway is an important metabolic pathway that plays a key role in multiple cellular processes. The aim of this study was to define whether the enzyme expression in mevalonate pathway changes during cardiovascular remodelling in spontaneously hypertensive rats (SHR). Methods and Results: Hearts and thoracic aortas were removed for the study of cardiovascular remodeling in SHR and Wistar-Kyoto rats (WKY). The protein expression of the enzymes in hearts, aortas and livers was analyzed by western blot. The histological measurements showed that the mass and the size of cardiomyocytes, the media thickness and the media cross-sectional area (MCSA) of the thoracic aorta were all increased in SHR since 3 weeks of age. In the heart, there was overexpression of some enzymes, including 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGR), farnesyl diphosphate synthase (FDPS), and geranylgeranyltransferase type I (GGTase-I), and downregulation of squalene synthetase (SQS) in SHR since 3 weeks of age. In the aorta, besides similar expressions of HMGR, SQS, FDPS and GGTase-I as in the heart, there was upregulation of farnesyltransferase α at 16 and 25 weeks of age and of farnesyltransferase β in 25-weeks-old SHR. Western blot demonstrated overexpression of HMGR and downregulation of SQS in SHR livers at all ages tested. Conclusions: The cardiovascular remodeling of SHR preceded the development of hypertension, and altered expression of several key enzymes in the mevalonate pathway may play a potential pathophysiological role in cardiovascular remodeling. (Circ J 2011; 75: 1409-1417)
論文 | ランダム
- アルカリプロテア-ゼ配合衣料用合成洗剤のヒト皮膚に対する安全性評価
- IgEを含めたアレルギーおよび免疫学の最近の進歩 (気道アレルギー(特集))
- ネフロ-ゼ症候群を呈し,ステロイド療法が著効を示したIgA腎症の1例
- 座談会 倉庫業の21世紀ビジョン (特集2 営業倉庫読本'99)
- 座談会 倉庫大手トップの視点 (営業倉庫読本′98)